Abstract: This application provides a data processing method, including: obtaining service data used to define a service feature, where the service data includes constant data, the service data is used to solve an objective function; obtaining at least one constraint item, where the constraint item includes a constraint relationship between a decision variable in the objective function and the constant data; splitting the constant data to obtain a plurality of data blocks, where each data block is corresponding to at least one sub-constraint item; allocating the plurality of data blocks to a plurality of compute nodes for parallel processing, so that the plurality of compute nodes generate a plurality of constraint blocks in parallel based on the plurality of data blocks and a corresponding sub-constraint item, to obtain a constraint matrix; and then determining a value of the decision variable based on the constraint matrix.

Abstract: The present invention relates to an avian influenza virus miRNA and the identification, detection and application thereof. In particular, a kind of specific microRNA, miR-HA-3p, is screened for the first time through detecting the microRNA expression levels in samples of animals with avian influenza. The experiments prove that the miR-HA-3p, as a microRNA marker, can be very effective in detecting avian influenza virus and avian influenza. Furthermore, inhibiting the function of miR-HA-3p can be very effective in relieving symptoms of avian influenza and treating avian influenza. The microRNA revealed in the present invention for the first time can be developed into a detection agent and a therapeutic agent as well as the corresponding kits for the detection and treatment of avian influenza (e.g., H5N1).

Abstract: Provided is non-coded RNA of in-vivo infected microorganisms, parasitic microorganisms, symbiotic microorganisms and identification and application thereof. Also provided is a method of identifying the non-coded RNA of in-vivo pathogen sources. The invention also provided a pharmaceutical composition containing an inhibitor for specifically inhibiting or blocking a RNA sequence and a method to treat a pathogen infectious disease or parasitic disease by administering an inhibitor, which inhibits a non-coding RNA sequence derived from a pathogen in the body of an animal, to an animal subject in need thereof.

Abstract: Provided is non-coded RNA of in-vivo infected microorganisms, parasitic microorganisms, symbiotic microorganisms and identification and application thereof. Also provided is a method of identifying the non-coded RNA of in-vivo pathogen sources.